B-Raf inhibitor 1 structure
|
Common Name | B-Raf inhibitor 1 | ||
---|---|---|---|---|
CAS Number | 1093100-40-3 | Molecular Weight | 478.936 | |
Density | 1.5±0.1 g/cm3 | Boiling Point | 735.4±60.0 °C at 760 mmHg | |
Molecular Formula | C26H19ClN8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | 398.6±32.9 °C |
Use of B-Raf inhibitor 1B-Raf inhibitor 1 is a potent Raf kinase inhibitor with Kis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively. |
Name | 1-N-(4-chlorophenyl)-6-methyl-5-N-[3-(7H-purin-6-yl)pyridin-2-yl]isoquinoline-1,5-diamine |
---|---|
Synonym | More Synonyms |
Description | B-Raf inhibitor 1 is a potent Raf kinase inhibitor with Kis of 1 nM, 1 nM, and 0.3 nM for B-RafWT, B-RafV600E, and C-Raf, respectively. |
---|---|
Related Catalog | |
Target |
B-Raf:1 nM (Ki) B-RafV600E:1 nM (Ki) c-Raf:0.3 nM (Ki) |
In Vitro | B-Raf inhibitor 1 (Compound 13) inhibits A375 and HCT-116 proliferation with IC50s of 0.31 and 0.72 μM, respectively. B-Raf inhibitor 1 (Compound 13) binds to and stabilizes B-Raf in a DFG-out, inactive conformation in which the ATP pocket is partially filled by Phe595 and Gly596 from the DFG motif. B-Raf inhibitor 1 (Compound 13) additionally exhibits low micromolar inhibition against wild type B-Raf cell lines, which may be due to off-target kinase activities or alternatively to pan-Raf inhibition, including Raf dimers[1]. |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 735.4±60.0 °C at 760 mmHg |
Molecular Formula | C26H19ClN8 |
Molecular Weight | 478.936 |
Flash Point | 398.6±32.9 °C |
Exact Mass | 478.142120 |
PSA | 104.30000 |
LogP | 4.97 |
Vapour Pressure | 0.0±2.4 mmHg at 25°C |
Index of Refraction | 1.798 |
Storage condition | 2-8℃ |
L1E |
B-Raf inhibitor 1 |
N-(4-Chlorophenyl)-6-methyl-N-[3-(1H-purin-6-yl)-2-pyridinyl]-1,5-isoquinolinediamine |
1,5-Isoquinolinediamine, N-(4-chlorophenyl)-6-methyl-N-[3-(9H-purin-6-yl)-2-pyridinyl]- |
3idp |
pyridylpurine aminoisoquinoline,1 |